GENE ONLINE|News &
Opinion
Blog

ESMO 2024
ESMO 2024 Prostate CancerBayer
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
ESMO 2024 highlights
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
ESMO 2024 ESMO 2024Cancer Screening
ESMO Introduces New Framework for Evaluating Tumor-Agnostic Potential of Cancer Treatments
2024-09-03
LATEST
General Lance W. Lord to Receive Space Foundation Lifetime Space Achievement Award for Leadership in Military Space Operations
2026-04-14
Ronald Kopas Reports 11.2 Percent Ownership in Delta Resources Following Private Share Acquisition
2026-04-14
Alcoa Corporation to Redeem $219 Million of 6.125% Notes Due 2028
2026-04-14
Eileen Akerson Appointed Chief Legal Officer of Brown & Brown, Inc.
2026-04-14
WeShop Schedules Fourth Quarter and Full Year 2025 Earnings Call for April 14, 2026
2026-04-14
Antalpha COO and CEO for U.S. and EMEA Regions Resign on April 14, 2026
2026-04-14
Novo Resources Appoints Geologist Rohan Williams to Advance Exploration Initiatives
2026-04-14
READ MORE
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
2026-04-29
BIO Korea 2026 (R&D & Collaborations)
Seoul, South Korea
2026-05-11
ASGCT (Gene and Cell Therapy Advances)
Boston, Massachusetts
2026-05-29
ASCO 2026 (Major Oncology Clinical Data)
Chicago, Illinois
2026-06-22
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
2026-06-25
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
SEE MORE
Scroll to Top